Moderate chronic administration of Vineatrol-enriched red wines improves metabolic, oxidative, and inflammatory markers in hamsters fed a high-fat diet

Molecular Nutrition and Food Research

Volumn 58, Issue 6, 2014, Pages 1212-1225

  Romain, Cindy ^a   Bresciani, Letizia ^b   Gaillet, Sylvie ^a   Feillet Coudray, Christine ^c   Calani, Luca ^b   Bonafos, Béatrice ^c   Vidé, Joris ^a   Rugani, Nathalie ^a   Ramos, Jeanne ^d   Rio, Daniele Del ^b   Cristol, Jean Paul ^a   Rouanet, Jean Max ^a  

^a UNIV MONTPELLIER   (France)

^b UNIVERSITY OF PARMA   (Italy)

^c University of Montpellier   (France)

^d GUI DE CHAULIAC HOSPITAL   (France)

Author keywords

Atherosclerosis; Liver inflammation; Oxidative stress; Stilbene rich wines; Vineatrol 30

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; CHOLESTEROL; GLUCOSE BLOOD LEVEL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 6; LEPTIN; PHENOL DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SIRTUIN 1; SIRTUIN 3; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VINEATROL;

ANALYSIS; ANIMAL; ANTAGONISTS AND INHIBITORS; ATHEROSCLEROSIS; BLOOD; DIET SUPPLEMENTATION; DRUG EFFECTS; ENZYMOLOGY; FATTY LIVER; GLUCOSE BLOOD LEVEL; HAMSTER; LIPID DIET; LIVER; MALE; MESOCRICETUS; METABOLIC SYNDROME X; METABOLISM; OXIDATIVE STRESS; WINE;

ADIPONECTIN; ANIMALS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHOLESTEROL; CRICETINAE; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; FATTY LIVER; INSULIN; INTERLEUKIN-6; LEPTIN; LIVER; MALE; MESOCRICETUS; METABOLIC SYNDROME X; NADPH OXIDASE; NF-KAPPA B; OXIDATIVE STRESS; PHENOLS; SIRTUIN 1; SIRTUIN 3; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; WINE;

EID: 84901913733     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300853     Document Type: Article

References (64)

1. Mathers, C. D., Loncar, D., Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006, 3, e442.
2. Charo, I. F., Taub, R., Anti-inflammatory therapeutics for the treatment of atherosclerosis. Nat. Rev. Drug Discov. 2011, 10, 365-376.
3. Sugamura, K., Keaney, J. F., Reactive oxygen species in cardiovascular disease. Free Radic. Biol. Med. 2011, 51, 978-992.
4. de Gaetano, G., Cerletti, C., Wine and cardiovascular disease. Nutr. Metab. Cardiovasc. Dis. 2001, 11, 47-50.
5. German, J. B., Walzem, R. L., The health benefits of wine. Annu. Rev. Nutr. 2000, 20, 561-593.
6. Renaud, S., de Lorgeril, M., Wine, alcohol, platelets, and the french paradox for coronary heart disease. Lancet 1992, 339, 1523-1526.
7. Giugliano, D., Dietary antioxidants for cardiovascular prevention. Nutr. Metab. Cardiovasc. Dis. 2000, 10, 38-44.
8. Szmitko, P. E., Verma, S., Antiatherogenic potential of red wine: clinician update. Am. J. Physiol. Heart Circ. Physiol. 2005, 288, H2023-H2030.
9. Opie, L. H., Lecour, S., The red wine hypothesis: from concepts to protective signalling molecules. Eur. Heart J. 2007, 28, 1683-1693.
10. Wallerath, T., Poleo, D., Li, H., Förstermann, U., Red wine increases the expression of human endothelial nitric oxide synthase. J. Am. Coll. Cardiol. 2003, 41, 471-478.
11. Corder, R., Douthwaite, J. A., Less, D. M., Khan, N. Q. et al., Endothelin-1 synthesis reduced by red wine. Nature 2001, 414, 863-864.
12. Pignatelli, P., Ghiselli, A., Buchetti, B., Carnevale, R. et al., Polyphenols synergistically inhibit oxidative stress in subjects given red and white wine. Atherosclerosis 2006, 188, 77-83.
13. Gin, H., Morlat, P., Ragnaud, J. M., Aubertin, J., Short-term effect of red wine (consumed during meals) on insulin requirement and glucose tolerance in diabetic patients. Diabetes Care 1992, 15, 546-548.
14. Chiva-Blanch, G., Urpi-Sarda, M., Ros, E., Valderas-Martinez, P. et al., Effects of red wine polyphenols and alcohol on glucose metabolism and the lipid profile: A randomized clinical trial. Clin. Nutr. 2013, 32, 200-206.
15. Napoli, C., Balestrieri, M. L., Sica, V., Lerman, L. O. et al., Beneficial effects of low doses of red wine consumption on perturbed shear stress-induced atherogenesis. Heart Vessels 2008, 23, 124-133.
16. Mukherjee, S., Lekli, I., Gurusamy, N., Bertelli, A. A. A., Das, D. K., Expression of the longevity proteins by both red and white wines and their cardioprotective components, resveratrol, tyrosol, and hydroxytyrosol. Free Radic. Biol. Med. 2009, 46, 573-578.
17. +, sirtuins, and cardiovascular disease. Curr. Pharm. Des. 2009, 15, 110-117.
18. Deng, X. Q., Chen, L. L, Li, N. X., The expression of SIRT1 in nonalcoholic fatty liver disease induced by high-fat diet in rats. Liver Int. 2007, 27, 708-715.
19. Gomez-Zorita, S., Fernandez-Quintela, A., Macarulla, M. T., Aguirre, L. et al., Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress. Br. J. Nutr. 2012, 107, 202-210.
20. Yoo, Y. J., Saliba, A. J., Prenzler, P. D., Ryan, D., Total phenolic content, antioxidant activity, and cross-cultural consumer rejection threshold in white and red wines functionally enhanced with catechin-rich extracts. J. Agric. Food Chem. 2012, 60, 388-393.
21. Müller, C., Ullman, K., Wilken, A., Winterhalter, P. et al., Potent antioxidative activity of Vineatrol® 30 grapevine-shoot extract. Biosci. Biotechnol. Biochem. 2009, 78, 1831-1836.
22. National Research Council. Guide for the Care and the Use of Laboratory Animals; National Institutes of Health Publication no.85-123 (rev.); U. S. Government Printing Office, Washington, DC 1985.
23. Reeves, P. G., Nielsen, F. H., Fahey, G. C., Jr., AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76 rodent diet. J. Nutr. 1993, 123, 1939-1951.
24. Weingand, K. W., Daggy, B. P., Quantitation of high-density lipoprotein cholesterol in plasma from hamsters by differential precipitation. Clin. Chem. 1990, 36, 575-580.
25. Jaouad, L., de Guise, C., Berrougui, H., Cloutier, M. et al., Age-related decrease in high density lipoprotein antioxidant activity is due to an alteration on the PON1's free sulfhydryl groups. Atherosclerosis 2006, 185, 191-200.
26. Sutra, T., Décordé, K., Riss, J., Dallas, C. et al., A commercial extract of fruits and vegetables, Oxxynea, acts as a powerful antiatherosclerotic supplement in an animal model by reducing cholesterolemia, oxidative stress, and NADPH oxidase expression. J. Agric. Food Chem. 2007, 55, 4258-4263.
27. Lago-Vanzela, E. S., Gomes Rebello, L. G., Mota Ramos, A., Stringheta, P. C. et al., Chromatic characteristics and color-related phenolic composition of Brazilian young red wines made from the hybrid grape cultivar BRS Violeta ("BRS Rúbea" × "IAC 1398-21"). Food Res. Int. 2013, 54, 33-43.
28. Oliveira, J., da Silva, M. A., Parola, A. J., Mateus, N. et al., Structural characterization of a A-type linked trimeric anthocyanin derived pigment occurring in a young Port wine. Food Chem. 2013, 141, 1987-1996.
29. Püssa, T., Floren, J., Kuldkepp, P., Raal, A., Survey of grapevine Vitis vinifera stem polyphenols by liquid chromatography-diode array detection-tandem mass spectrometry. J. Agric. Food Chem. 2006, 54, 7488-7494.
30. Romain, C., Gaillet, S., Carillon, J., Vidé, J. et al., Vineatrol and cardiovascular disease: beneficial effects of a vine-shoot phenolic extract in a hamster atherosclerosis model. J. Agric. Food Chem. 2012, 60, 11029-11036.
31. Quesada, H., del Bas, J. M., Pajuelo, D., Diaz, S. et al., Grape seed proanthocyanidins correct dyslipidemia associated with a high-fat diet in rats and repress genes controlling lipogenesis and VLDL assembling in liver. Int. J. Obes. 2009, 33, 1007-1012.
32. Suwannaphet, W., Meeprom, A., Yibchok-Anun, S., Adisakwattana, S., Preventive effect of grape seed extract against high-fructose diet-induced insulin resistance and oxidative stress in rats. Food Chem. Toxicol. 2010, 48, 1853-1857.
33. Li, L., Hai, J., Zhang, Y., Peng, H. et al., Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease. Food Chem. Toxicol. 2014, 63, 166-173.
34. Brasnyó, P., Molnár, G. A., Mohás, M., Markó, L. et al., Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br. J. Nutr. 2011, 106, 383-389.
35. Li, Y., Ding, L., Hassan, W., Abdelkader, D., Shang, J., Adipokines and hepatic insulin resistance. J. Diabetes Res. 2013, 170532.
36. Matsubara, M., Maruoka, S., Katayose, S., Inverse relationship between plasma adiponectine and leptin concentrations in normal-weight and obese women. Eur. J. Endocrinol. 2002, 147, 173-180.
37. Berglund, E. D., Vianna, C. R., Donato, J., Jr., Kim, M. H. et al., Direct leptin action on POMC neurons regulates glucose homeostasis and hepactic insulin sensitivity in mice. J. Clin. Invest. 2012, 122, 1000-1009.
38. Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y. et al., The fat-derived hormone adiponectin resverses insulin-resistance associated woth both lipoatrophy and obesity. Nat. Med. 2001, 7, 941-946.
39. Décordé, K., Teissèdre, P. L., Sutra, T., Ventura, E. et al., Chardonnay grape seed procyanidin extract supplementation prevents high-fat diet-induced obesity in hamsters by improving adipokine imbalance and oxidative stress markers. Mol. Nutr. Food Res. 2009, 53, 659-666.
40. Décordé, K., Ventura, E., Lacan, D., Ramos, J. et al., An SOD rich melon extract Extramel prevents aortic lipids and liver steatosis in diet-induced model of atherosclerosis. Nutr. Metab. Cardiovasc. Dis. 2010, 20, 301-307.
41. Sezer, E. D., Sozmen, E. Y., Nart, D., Onat, T., Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotis plaque formation. Vasc. Health Risk Manag. 2011, 7, 333-343.
42. Agbor, G. A., Akinfiresoye, L., Sortino, J., Johnson, R. et al. Piper species protect cardiac, hepatic and renal antioxidant status of atherogenic diet fed hamsters. Food Chem. 2012, 134, 1354-1359.
43. Covas, M. I., Gambert, P., Fito, M., de la Torre, R., Wine and oxidative stress: up-to-date evidence of the effects of moderate wine consumption on oxidative damage in humans. Atherosclerosis 2010, 20, 297-304.
44. Pedret, A., Valls, R. M., Fernandez-Castillejo, S., Catalan, U. et al., Polyphenol-rich foods exhibit DNA antioxidative properties and protect the glutathione system in healthy subjects. Mol. Nutr. Food Res. 2012, 56, 1025-1033.
45. Estruch, R., Sacanella, E., Mota, F., Chiva-Blanch, G. et al., Moderate consumption of red wine, but not gin, decreases erythrocyte superoxide dismutase activity: a randomised cross-over trial. Nutr. Metab. Cardiovasc. Dis. 2011, 21, 46-53.
46. Durrington, P. N., Mackness, B., Mackness, M. I., Paraoxonase and atherosclerosis. Arterioscler. Thromb. Vasc. Dis. 2001, 21, 473-480.
47. Shih, D. M., Xia, Y. R., Wang, X. P., Miller, E. et al., Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis. J. Biol. Chem. 2000, 275, 17527-17535.
48. She, Z. G., Chen, H. Z., Yan, Y., Li, H. et al., The human paraoxonase gene cluster as a target in the treatment of atherosclerosis. Antioxid. Redox Signal 2012, 16, 597-632.
49. Thomàs-Moyà, E., Gianotti, M., Proenza, A. M., Lladó, I., Paraoxonase 1 response to a high-fat diet: gender differences in the factors involved. Mol. Med. 2007, 13, 203-209.
50. Cabana, V. G., Reardon, C. A., Feng, N., Neath, S. et al., Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response. J. Lipid Res. 2003, 44, 780-792.
51. Cannizzo, B., Luján, A., Estrella, N., Lembo, C. et al., Insulin resistance promotes early atherosclerosis via increased proinflammatory proteins and oxidative stress in fructose-fed ApoE-KO mice. Exp. Diabetes Res. 2012, 941304.
52. Rolo, A. P., Teodoro, J. S., Palmeira, C. M., Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic. Biol. Med. 2012, 52, 59-69.
53. Bhatia, L. S., Curzen, N. P., Calder, P. C., Byrne, C. D., Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur. Heart J. 2012, 33, 1190-1200.
54. Day, C. P., James, O. F., Steatohepatitis: a tale of two «hits»? Gastroenterology 1998, 114, 842-845.
55. Pamukcu, B., Lip, G. Y., Shantsila, E., The nuclear factor-kappa B pathway in atherosclerosis: a potential therapeutic target for atherothrombotic vascular disease. Thromb. Res. 2011, 128, 117-123.
56. Morgan, M. J., Liu, Z. G., Crosstalk of reactive oxygen species and NF-κB signaling. Cell. Res. 2011, 21, 103-115.
57. Kang, O. H., Jang, H. J., Chae, H. S., Oh, Y. C. et al., Anti-inflammatory mechanisms of resveratrol in activated HMC-1 cells: pivotal roles of NF-kappaB and MAPK. Pharmacol. Res. 2009, 59, 330-337.
58. Li, L., Hai, J., Li, Z., Zhang, Y. et al., Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease. Food Chem. Toxicol. 2014, 63, 166-173.
59. Nogueiras, R., Habegger, K. M., Chaudhary, N., Finan, B. et al., Sirtuin 1 and sirtuine 3: physiological modulators of metabolism. Physiol. Rev. 2012, 92, 1479-1514.
60. Chung, J. H., Manganiello, V., Dyck, J. R., Resveratrol as a calorie restriction mimetic: therapeutic implications. Trends Cell Biol. 2012, 22, 546-554.
61. Xu, Q., Si, L. Y., Resveratrol role in cardiovascular and metabolic health and potential mechanims of action. Nutr. Res. 2012, 32, 648-658.
62. Aoun, M., Michel, F., Fouret, G., Casas, F. et al., A polyphenol extract modifies quantity but not quality of liver fatty acid content in high-fat-high-sucrose diet-fed rats: possible implication of the sirtuin pathway. Br. J. Nutr. 2010, 104, 1760-1767.
63. + metabolism and SIRT1 activity. Nature 2009, 458, 1056-1060.
64. Price, N. L., Gomes, A. P., Ling, A. J., Duarte, F. V. et al., SIRT1 is required for AMPK activation and beneficial effects of resveratrol on mitochondrial fucntion. Cell Metab. 2012, 15, 675-690.